Correction: N-acetylcysteine modulates neutrophil-driven immune and metabolic pathways in steatotic liver ischemia–reperfusion injury - Scorecard - MDSpire

Correction: N-acetylcysteine modulates neutrophil-driven immune and metabolic pathways in steatotic liver ischemia–reperfusion injury

  • By

  • Jiman Kang

  • Digvijay Patil

  • Ryan Hackett

  • Yuki Cui

  • Kesha Oza

  • Abigail Rutkowski

  • Jedson R. Liggett

  • Henghong Li

  • Suman Ranjit

  • DongHyang Kwon

  • Bhaskar Kallakury

  • Chris Albanese

  • Gabriel E. Gondolesi

  • Udeme Ekong

  • Wanxing Cui

  • Khalid Khan

  • Thomas M. Fishbein

  • Alexander Kroemer

  • July 7, 2026

  • 0 min

Share

Clinical Scorecard: Correction: The Role of N-acetylcysteine in Modulating Neutrophil-Driven Immune and Metabolic Responses During Ischemia-Reperfusion Injury in Steatotic Liver

At a Glance

CategoryDetail
ConditionIschemia-Reperfusion Injury
Key MechanismsN-acetylcysteine modulates neutrophil-driven immune and metabolic pathways
Target PopulationPatients with steatotic liver conditions
Care SettingClinical research and immunology

Key Highlights

  • Correction of funding statement to reflect support from CRDO
  • Updated data availability statement for datasets
  • Revised Supplementary File 1 published
  • Errors do not affect scientific conclusions

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Patients with steatotic liver undergoing ischemia-reperfusion injury

          N-acetylcysteine may influence immune responses

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content